Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03670836 · ClinicalTrials.gov registry record · Phase 4
Comparison of Misoprostol Ripening Efficacy With Dilapan
A Phase 4 study of Induced; Birth and Labor Onset and Length Abnormalities, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 307
- Enrollment target
- 2
- Study locations
NCT03670836 is a Phase 4 study of Induced; Birth and Labor Onset and Length Abnormalities that has completed, run by Columbia University. The registered enrollment target is 307 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03670836, a Phase 4 study of Induced; Birth and Labor Onset and Length Abnormalities, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 307 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to find out if Dilapan works as well as Misoprostol for preparing the mouth of the uterus (cervix) for inducing labor in women who need to undergo this procedure. The primary objective is to assess the efficacy of Dilapan for cervical ripening compared to Misoprostol in women undergoing Induction of labor (IOL) at or more than 37 weeks gestation.
Conditions Studied
Interventions
- DRUG Misoprostol
- DEVICE Dilapan
Study Locations (2)
New York
- New York Presbyterian - Allen Hospital - New York
Texas
- University of Texas - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2018-11-15 |
| Est. Completion | 2021-07-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03670836
The ClinicalTrials.gov registry entry for NCT03670836 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 307 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Induced; Birth appearing as the primary indexed condition, and to 2 interventions - of which Misoprostol is the first listed.
NCT03670836 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Texas.
Frequently Asked Questions
What is clinical trial NCT03670836 about?
NCT03670836 is a clinical study titled "Comparison of Misoprostol Ripening Efficacy With Dilapan". The purpose of this study is to find out if Dilapan works as well as Misoprostol for preparing the mouth of the uterus (cervix) for inducing labor in women who need to undergo this procedure. The primary objective is to assess the efficacy of Dilapan for cervical ripening compared to Misoprostol in ...
What is the current status of trial NCT03670836?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 307 participants. The study started on 2018-11-15. Estimated completion is 2021-07-21.
What conditions does trial NCT03670836 study?
This clinical trial studies the following conditions: Induced; Birth, Labor Onset and Length Abnormalities.
What interventions are being tested in trial NCT03670836?
The interventions under investigation include: Misoprostol (DRUG), Dilapan (DEVICE).
Who is sponsoring clinical trial NCT03670836?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03670836 being conducted?
This trial has 2 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Induced; Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.